vTv Therapeutics (VTVT) Price to FCF (2015 - 2026)

vTv Therapeutics has disclosed Price to FCF across 12 years of filings, most recently posting 40.83 for Q2 2026.

• In Q2 2026, Price to FCF fell 109.13% year-over-year to 40.83; the TTM figure through Jun 2026 stood at 27.97 (down 519.86% YoY), while the FY2025 annual figure was 13.4, down 323.68% from the prior year.
• Price to FCF came in at 40.83 for Q2 2026 at vTv Therapeutics, down from 53.76 in the prior quarter.
• In the past five years, Price to FCF ranged from a high of 106.68 in Q2 2022 to a low of 63.68 in Q1 2022.
• Average Price to FCF over 5 years is 10.37, with a median of 14.84 recorded in 2023.
• Year-over-year, Price to FCF tumbled 212.93% in 2025 and soared 366.61% in 2026.
• Over 5 years, Price to FCF stood at 10.07 in 2022, then decreased by 8.19% to 10.9 in 2023, then plunged by 52.51% to 16.62 in 2024, then slumped by 119.62% to 36.51 in 2025, then fell by 11.84% to 40.83 in 2026.
• Per Business Quant data, the three most recent Price to FCF figures were 40.83 in Q2 2026, 53.76 in Q1 2026, and 36.51 in Q4 2025.